| RS1176222161 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS117626343 |
SLC5A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 1, Thyroid dyshormonogenesis 1 |
| RS1176301490 |
SNAP29
|
Health Risk |
Pathogenic |
— |
| RS1176314553 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1176335599 |
HNF4A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS1176339464 |
POMGNT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS1176350430 |
POLH
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum variant type, Xeroderma pigmentosum variant type |
| RS1176366316 |
GOSR2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS117639561 |
SULF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1176397159 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1176402115 |
UPB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of beta-ureidopropionase, Inborn genetic diseases |
| RS1176407542 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, NEB-related disorder |
| RS117642173 |
RECQL4
|
Health Risk |
Pathogenic |
Rothmund-Thomson syndrome type 2, Baller-Gerold syndrome |
| RS1176445102 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS117646477 |
GATA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrioventricular septal defect 5, Neonatal insulin-dependent diabetes mellitus |
| RS117647282 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1176474582 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile hypophosphatasia, Hypophosphatasia |
| RS1176480523 |
ANO5
|
Health Risk |
Pathogenic |
— |
| RS1176505942 |
ANO10
|
Health Risk |
Pathogenic |
— |
| RS1176517015 |
EXOSC9
|
Health Risk |
Pathogenic |
— |
| RS1176521918 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS1176526663 |
RGS9
|
Health Risk |
Likely pathogenic |
— |
| RS1176542971 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS1176553821 |
TYRP1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1176555010 |
SCO1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS1176555925 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS117656396 |
MPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1176567641 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1176571450 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS1176579720 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS117659667 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS117661165 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS117662905 |
FOXP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Childhood apraxia of speech, Childhood apraxia of speech |
| RS1176639498 |
RTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS1176654400 |
HK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemolytic anemia due to hexokinase deficiency, Hemolytic anemia due to hexokinase deficiency |
| RS1176654682 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1176659689 |
GCK
|
Health Risk |
Likely pathogenic |
— |
| RS1176670439 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 14 |
| RS117667651 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS117668001 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS1176694083 |
RDH11
|
Health Risk |
Pathogenic |
— |
| RS117670586 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Rothmund-Thomson syndrome |
| RS1176709391 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS1176710652 |
INVS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS117672175 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, Ehlers-Danlos syndrome |
| RS1176723126 |
FOXE3
|
Health Risk |
Pathogenic |
Congenital primary aphakia, Anterior segment dysgenesis |
| RS1176732027 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1176738073 |
EVC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS1176744330 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS1176770868 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, CBS-related disorder |
| RS1176780540 |
G6PC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS117678424 |
PTF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome, Neonatal insulin-dependent diabetes mellitus |
| RS117678561 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS117678693 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS1176797481 |
RNASEH2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Aicardi-Goutieres syndrome 2, Aicardi-Goutieres syndrome 2 |
| RS1176799813 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1176811808 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS1176822890 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS117683234 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, SPG11-related disorder |
| RS1176835993 |
TDRD12
|
Health Risk |
Likely pathogenic |
Male infertility, Male infertility |
| RS1176843691 |
LOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1176851202 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS117685425 |
SLC24A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1D, Congenital stationary night blindness 1D |
| RS117685582 |
CYP24A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercalcemia, infantile |
| RS1176858193 |
GCK
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1176869304 |
PRPF8
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS117687681 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, Connective tissue disorder |
| RS117687848 |
ALG12
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG12-congenital disorder of glycosylation, ALG12-related disorder |
| RS117688560 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS117688574 |
COG6
|
Health Risk |
Conflicting classifications of pathogenicity |
COG6-congenital disorder of glycosylation, Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome |
| RS117688924 |
P3H2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopia, high |
| RS1176902020 |
C8B
|
Health Risk |
Pathogenic/Likely pathogenic |
C8B-related disorder, C8B-related disorder |
| RS1176910976 |
NME8
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 6, Primary ciliary dyskinesia |
| RS1176911729 |
CCNO
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1176922412 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Osteogenesis imperfecta type I |
| RS1176927796 |
CC2D2A
|
Health Risk |
Likely pathogenic |
— |
| RS1176952770 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1176959485 |
RECQL4
|
Health Risk |
Likely pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1176960115 |
ALDOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary fructosuria, Hereditary fructosuria |
| RS1176975147 |
PGAP1
|
Health Risk |
Likely pathogenic |
— |
| RS1176988972 |
NRK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1176993096 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS1176998293 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS1177043110 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, RAD51C-related disorder |
| RS1177052380 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS1177054873 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS117706710 |
AMPD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocyte AMP deaminase deficiency, AMPD3-related disorder |
| RS1177091005 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS1177091667 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS117710834 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS117711403 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS1177166077 |
WRN
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS1177198729 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1177201180 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1177246173 |
BBS12
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 12 |
| RS1177257719 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS117725825 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS1177268940 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1177306016 |
GUSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS1177306699 |
RIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 8, Cardiovascular phenotype |